Results 151 to 160 of about 1,313 (182)
Some of the next articles are maybe not open access.
Treatment of psoriatic arthritis by extracorporeal photochemotherapy
British Journal of Dermatology, 1990Five patients with long-standing seronegative arthritis resistant to conventional therapy and who also had psoriasis of the skin were treated with photopheresis. This mode of treatment combines a lymphocyte-enrichment procedure with 8-methoxypsoralen-photochemotherapy.
Josef S. Smolen +4 more
openaire +3 more sources
The course of anticoagulation after extracorporeal photochemotherapy
Photodermatology, Photoimmunology & Photomedicine, 2005During extracorporeal photochemotherapy (ECP) heparin is added to the extracorporeal circulation to avoid clotting. It has not been investigated whether and to what extend this procedure influences coagulation in patients after ECP. In this study activated partial thrombaplastin time (aPTT) and anti‐factor Xa were monitored for up to 4 h after ECP in ...
P. Quehenberger +4 more
openaire +3 more sources
[Extracorporeal photochemotherapy].
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2010Photopheresis or extracorporeal photochemotherapy (ECP) is a cellular therapy which combines a leukapheresis followed by ex vivo treatment using psoralen and ultraviolet A irradiation before reinfusion into the patient. Its mechanisms of action remain unclear and selective photodestruction of leukocytes cannot explain the long-lasting immunomodulatory ...
Viguier, M. +3 more
openaire +3 more sources
Dosage Guidelines: Extracorporeal Photochemotherapy (Photopheresis)
Archives of Dermatology, 1990To the Editor.— Extracorporeal photochemotherapy (photopheresis) has been approved for the treatment of cutaneous T-cell lymphoma. During the clinical trial that documented the effectiveness of this therapy, 1 patients were treated with a minimum of 0.6 mg/kg crystalline 8-methoxypsoralen (8-MOP).
Francis P. Gasparro +2 more
openaire +3 more sources
Extracorporeal Photochemotherapy ‐ Present and Future
Vox Sanguinis, 2000Extracorporeal photochemotherapy (ECP) was introduced by Edelson and co‐workers in 1985. Since then the therapy, though still controversial in specific indications, has received wide acceptance and is presently been used in over 160 centers in Europe and the U.S.A. for a number of important dermatological and non‐dermatological indications.
openaire +2 more sources
Applications of Extracorporeal Photochemotherapy in “Non-oncological” Diseases
The International Journal of Artificial Organs, 1993Photopheresis (ECP) is a new therapy for oncological and autoimmune diseases consisting in the reinfusion of 3-9x 109 leukocytes, taken from the patient by leukapheresis, and treated in an extracorporeal system with 8-methoxypsoralen and ultraviolet light A.
Dall'Amico R +8 more
openaire +5 more sources
Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis
Clinical Immunology, 2012The aim of this study was to evaluate the clinical and immunomodulatory effects of extracorporeal photochemotherapy (ECP) in systemic sclerosis (SSc). We enrolled 16 patients with diffuse cutaneous SSc, who received 12 ECP treatments in total. After ECP treatments, the dermal thickness reduced and the mobility of joints improved.
Papp, Gábor +6 more
openaire +2 more sources
Treatment of cutaneous T-cell lymphoma with extracorporeal photochemotherapy
Journal of the European Academy of Dermatology and Venereology, 1996AbstractBackground Cutaneous T‐cell lymphoma (CTCL) and its leukemic erythrodermic form (Sézary syndrome) are malignancies cies of CD4+ T lymphocytes. Extracorporeal photochemotherapy (ECP) selectively affects autoreactive as well as malignant T lymphocytes.
Alexander Konstantinow +1 more
openaire +3 more sources
Extracorporeal Photochemotherapy (Extracorporal Photophoresis)
2000Extracorporeal photo chemotherapy (or photophoresis) is a rather new light-based biological therapeutic method, which was originally developed exclusively to treat the pathologically altered cells of cutaneous malignant T-cell lymphoma outside the body, using a light sensitizer and long-wave ultraviolet irradiation.
openaire +2 more sources
Extracorporeal Photochemotherapy for Drug-Resistant Pemphigus Vulgaris
Annals of Internal Medicine, 1990Excerpt The extracorporeal exposure of pathogenic peripheral blood leukocytes to the natural compound 8-methoxypsoralen (8-MOP) and ultraviolet A radiation has provided great benefit in certain adv...
Gerald S. Lazarus +7 more
openaire +3 more sources